MAPK
-
AS 602801 (Bentamapimod)
Catalog No. A11296 JNK 抑制剂AS 602801 (Bentamapimod)是一种新型口服活性Jun激酶抑制剂。 了解更多 -
CC-930 (Tanzisertib)
Catalog No. A13564 JNK 抑制剂CC-930在蛋白底物c-Jun的JNK依赖性磷酸化中与ATP动力学竞争,并且对JNK的所有同工型均有效(Ki(JNK1)= 44±3 nM,IC50(JNK1)= 61 nM,Ki(JNK2 )= 6.2±0.6 nM,IC50(JNK2)= 5 nM,IC50(JNK3)= 5 nM),对MAP激酶ERK1和p38a具有选择性,IC50分别为0.48和3.4μM。 了解更多 -
CEP-1347
Catalog No. A13565 -
CC-401 hydrochloride
Catalog No. A15037 -
JIP-1 (153-163)
Catalog No. A16041 JNK 抑制剂JIP-1 (153-163)是c-Jun N末端激酶(JNK)的肽抑制剂,基于JNK相互作用蛋白1(JIP-1)的153-163残基。以微摩尔范围的亲和力与JNK结合,并最小程度地抑制p38和ERK。 了解更多 -
TCS JNK 5a
Catalog No. A11969 JNK 抑制剂 IXTCS JNK 5a是JNK2和JNK3的高度选择性抑制剂(对于JNK3,JNK2,JNK1和p38β,pIC50值分别为6.7、6.5,<5.0和<4.8)。 了解更多 -
Vacquinol-1
Catalog No. A15883 -
IQ-1S
Catalog No. A16062 -
Anisomycin
Catalog No. A11271 SAPKs/JNKs activatorAnisomycin是一种吡咯烷类抗生素,用作抑制蛋白质合成的抗真菌抗生素,也是SAPK/JNK的有效激活剂。 了解更多 -
SR 3576
Catalog No. A16020 -
c-JUN peptide
Catalog No. A16045 -
SR 11302
Catalog No. A14950 -
PLX4032 (Vemurafenib)
Catalog No. A10739 Raf 抑制剂PLX4032(Vemurafenib)也称为RG7204,Vemurafenib,R7204,RO5185426。PLX4032是B-raf抑制剂,IC50为44 nM。 了解更多 -
Sorafenib Tosylate (Nexavar)
Catalog No. A10001 Raf 抑制剂Sorafenib Tosylate (Nexavar)是几种酪氨酸蛋白激酶(VEGFR和PDGFR)和RAF/MEK/ERK级联抑制剂的新型小分子抑制剂,Raf-1,wt BRAF和V599E突变型BRAF的IC50为6、22、38 nM。 了解更多 -
Regorafenib (BAY 73-4506)
Catalog No. A10250 VEGFR 抑制剂Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种针对肿瘤及其脉管系统的口服生物利用型多激酶抑制剂。 了解更多 -
Dabrafenib (GSK2118436A)
Catalog No. A11381 Raf 抑制剂Dabrafenib (GSK2118436A)是一种有效且选择性的B-RAF蛋白激酶抑制剂,具有V600E突变,目前正在临床试验中。 了解更多 -
NVP-BHG712
Catalog No. A10661 EphB4 抑制剂NVP-BHG712是EphB4激酶的选择性抑制剂,在体外对EphB4的选择性超过40多种其他激酶(包括FGFR3)。 了解更多 -
LGX 818 (Encorafenib)
Catalog No. A13226 Selective B-RAF 抑制剂LGX 818 (Encorafenib)是一种Raf激酶抑制剂,具有潜在的抗肿瘤活性。 了解更多 -
B-Raf-inhibitor 1
Catalog No. A14122 B-Raf 抑制剂B-Raf inhibitor 1是有效的选择性B-Raf抑制剂,对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。 了解更多 -
CEP-32496 hydrochloride
Catalog No. A15040 Raf 抑制剂CEP-32496 hydrochloride是野生型BRAF,V600E突变型BRAF和c-Raf的高效抑制剂,Kd值分别为14 nM,36 nM和39 nM。 了解更多 -
Dabrafenib Mesylate
Catalog No. A15059 Raf 抑制剂Dabrafenib Mesylate是一种新颖,有效和选择性的Raf激酶抑制剂,能够抑制野生型B-Raf,B-RafV600E和c-Raf的激酶活性,IC50值分别为3.2、0.8和5.0 nM。 了解更多 -
ML 786 dihydrochloride
Catalog No. A11211 Raf 抑制剂ML 786 dihydrochloride是一种有效的Raf激酶抑制剂(B-RafV600E,C-Raf和野生型B-Raf的IC50值分别为2.1、2.5和4.2 nM)。 了解更多 -
HG6-64-1
Catalog No. A16022 -
RAF mutant-IN-1
Catalog No. A19011 Raf nhibitorRAF mutant-IN-1 is a RAF kinase inhibitor, extracted from patent WO2019107987A1, with IC50 values of 21 nM, 30 nM and 392 nM for C-RAF340D/Y341D, B-RAFV600E and B-RAFWT, respectively. 了解更多 -
Belvarafenib
Catalog No. A13177 pan RAF inhibitorBelvarafenib (HM95573) is a potent and pan RAF (Rapidly Accelerated Fibrosarcoma) inhibitor, with IC50s of 56 nM, 7 nM and 5 nM for B-RAF, B-RAFv600E and C-RAF respectively. 了解更多 -
Regorafenib Hydrochloride
Catalog No. A11546 VEGFR1/2/3/PDGFRβ/Kit/RET/Raf-1 inhibitorRegorafenib Hydrochloride is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively. 了解更多 -
B-Raf IN 1
Catalog No. A21055 B-Raf kinase inhibitorB-Raf IN 1 is a potent and selective B-Raf kinase inhibitor with an IC50 of 24 nM. 了解更多 -
B-Raf inhibitor 1 dihydrochloride
Catalog No. A21834 Raf kinase inhibitorB-Raf inhibitor 1 dihydrochloride is a potent Raf kinase inhibitor with Kis of 1 nM, 1 nM, and 0.3 nM for B-RafWT, B-RafV600E, and C-Raf, respectively. 了解更多 -
Lifirafenib
Catalog No. A20988 Raf/EGFR inhibitorLifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively. 了解更多 -
RAF265 (CHIR-265)
Catalog No. A10773 RAF/VEGFR 抑制剂RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf突变以预防癌症。 了解更多 -
GDC-0879
Catalog No. A10420 -
AZ628
Catalog No. A11063